Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/REGN
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Regeneron Pharmaceuticals Inc (REGN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Regeneron Pharmaceuticals (REGN) trades at $810.31, down 2.1% today, with strong fundamentals including 84.9% gross margins and consistent earnings beats. The stock shows bullish technical signals with support at $805 and resistance at $838, while analyst consensus remains strongly positive with 69% buy ratings. Recent news highlights multiple class action lawsuits related to clinical trial disclosures, creating near-term sentiment headwinds despite solid financial performance.
Outlook remains cautiously optimistic given strong profitability and analyst support, though legal risks and clinical trial uncertainties present challenges. The stock trades above consensus price target of $756.82, suggesting limited near-term upside potential despite robust fundamentals and institutional confidence.
Read full analysis

Key Stats

  • Market Cap
    $83.43B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $852.03
  • 52W Low
    $555.51
  • Typical Hold Time
    -
  • Enterprise Value
    $78.14B
  • Div Yield
    0.46%
  • Trading Activity
    -
$807.6
52W Low: $555.51
25 Sep 2025
52W High: $852.03
02 Sep 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $555.51 and a high of $852.03, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Most Recent News

Content is generated by Aura AI

TSMC posts record August revenue, up 53% YoY, driven by strong AI chip demand

Taiwan Semiconductor Manufacturing Co. (TSMC) reported record monthly revenue of $16.35 billion for August, a 53.3% increase from the previous year and a 10.1% rise from July. The surge is driven by robust demand for chips used in artificial intellig...

Company Fundamentals
4 hours ago
CNBC
Bullish
news icon
TSMC posts record August revenue, up 53% YoY, driven by strong AI chip demand

Vistra rated Buy at $152 on stronger electricity demand and solid contracts boosting earnings visibility.

Vistra is rated Buy at $152 following a 12% price pullback, improved EBITDA, and a positive outlook driven by growing electricity demand in key US markets like ERCOT and PJM. The company's value is supported by demand from data centers, electrificati...

Analyst Insights
4 hours ago
Seeking Alpha
Bullish
news icon
Vistra rated Buy at $152 on stronger electricity demand and solid contracts boosting earnings visibility.

Clarity Act likely to pass, Coinbase CEO says, promising clearer crypto rules and institutional growth.

Coinbase CEO Brian Armstrong expressed confidence that the Clarity Act, a U.S. federal bill to regulate digital assets, is likely to pass the Senate with broad support from crypto firms and banks. The legislation aims to clarify oversight between the...

Market News
4 hours ago
CNBC
Bullish
news icon
Clarity Act likely to pass, Coinbase CEO says, promising clearer crypto rules and institutional growth.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $83.43B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $852.03
  • 52W Low
    $555.51
  • Typical Hold Time
    -
  • Enterprise Value
    $78.14B
  • Div Yield
    0.46%
  • Trading Activity
    -
$807.6
52W Low: $555.51
25 Sep 2025
52W High: $852.03
02 Sep 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $555.51 and a high of $852.03, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!